Arrêt de service programmé du vendredi 10 juin 16h jusqu’au lundi 13 juin 9h. Pour en savoir plus
Accéder directement au contenu Accéder directement à la navigation
Communication dans un congrès

The marine mussel Mytilus galloprovincialis bioconcentrate and metabolize antidepressant pharmaceutical venlafaxine

Abstract : A significant investment in research has been conducted to define exposures andpotential hazards of pharmaceuticals in freshwater and terrestrial ecosystems. Incontrast, comparatively few empirical studies have been conducted forpharmaceuticals that are likely to enter coastal and marine ecosystems[1,2]. Theantidepressant venlafaxine (VLF) and some of its metabolites were recently foundin mussels caged in a coastal site receiving treated wastewater[3]. In those marineorganisms, very scarce data is available on the accumulation and/or metabolisationof pharmaceuticals. Consequently, it appears hazardous to conclude on the originof those metabolites in mussels, which could include a bioaccumulation throughdirect exposure as well as a metabolism of VLF in mussels. The aim of the presentwork was to quantify the accumulation of VLF in the marine mussel Mytilusgalloprovincialis and to evaluate the possible metabolism in laboratory controlledexperiments. The accumulation of VLF was evaluated in the whole mussel tissuesafter 1, 3 and 7 days of semi-static exposure by water (10µg L-1day-1) followedby 1, 3 and 7 days of depuration. Under those conditions, VLF attained an averagetissue concentration of (n=3) 2146.3 ± 156.0 ng g-1 dry weight (d.w.) in sevendays. The kinetic bioconcentration factor (BCF) was 265 ± 19 L kg-1 d.w. Sevendays of depuration allowed a decrease of tissue concentration to 21 ± 1.0 ng g-1d.w. Four VLF metabolites were quantified in mussel tissues and excreted inwater. The kinetics of those metabolites in water confirmed the metabolism ofVLF by mussels. Complementary experiment conducted at 1, 10 and 100 µL L-1nominal concentration clearly confirmed that M. galloprovincialis metabolizeVLF, with the quantification of studied metabolites excepted the NNO-VLF.These results gave a first approach on the ability of mussel to metabolizepharmaceuticals. Together with bioaccumulation information, this study provideda first approach on the pharmacokinetics of a pharmaceutical in a wild marinespecies, underlining the need of further experiments to better understand howvenlafaxine modulate the receptors in mussels and how exposure to thisantidepressant affects physiological functions of invertebrates.
Type de document :
Communication dans un congrès
Liste complète des métadonnées
Contributeur : Pascale Roussel Connectez-vous pour contacter le contributeur
Soumis le : vendredi 10 mai 2019 - 17:33:26
Dernière modification le : mardi 17 mai 2022 - 13:40:03


  • HAL Id : hal-02125979, version 1



Elena Gomez, C. Boillot, M. Martinez Bueno, Dominique Munaron, Mathieu Olivier, et al.. The marine mussel Mytilus galloprovincialis bioconcentrate and metabolize antidepressant pharmaceutical venlafaxine. 26th Annual Meeting of the Society of Environmental Toxicology and Chemistry (SETAC Europe), May 2016, Nantes, France. ⟨hal-02125979⟩



Consultations de la notice